Back to Industry Corner

 

 

 

Personalized transplant surveillance.
Better outcomes.
CareDx is committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey
We are the only company that is 100% focused on Transplantation

Drive better outcomes for kidney transplant recipients

AlloSure is the leading cfDNA test for noninvasive transplant surveillance used in over 150 US transplant centers and over 25,000 patients
Dr Steven Potter and Dr Tarek Alhamad discusses his view on using AlloSure to monitor his transplant patients
Download AlloSure Brochure
AlloSure Helps Guide Kidney Transplant Patient Management

Combined with other recent publications on AlloSure clinical utility, RADAR suggests a new standard for assessing AlloSure levels and reinforces the importance of monitoring changes in AlloSure levels over time.

  • High PPV for ABMR in DSA-positive patients
  • Differentiates borderline/TCMR1A patients
  • 95% NPV for active rejection at 0.21% threshold
Learn more: https://www.caredx.com/radar
The cutting edge solution to detect donor-derived cell-free DNA

AlloSeq cfDNA is a kit based solution that enables measurement of dd-cfDNA through a blood test.
*Not available in the US

Download AlloSeq Brochure
CareDx at TTS 2020

4 Virtual Symposiums

September 14th
11 AM KST / 10 PM EST (Sept 13th)

See details

September 14th
12 PM CET / 6 AM EST

Learn More

September 14th
1 PM EST / 7 PM CET

Learn More

September 15th
1 PM EST / 7 PM CET

Learn More